- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05824598
Multifunctional Approach in Cardiac Surgery (TITANIC)
OsteopaThic, logopedIc and Psychological Assessment To Improve Outcome in pAtieNts undergoIng Cardiac Surgery: a Randomized Clinical Trial (TITANIC Trial)
Postoperative pain and swallowing disorders are complex, multifactorial phenomenon that frequently occur after cardiac surgery. Preoperative anxiety and the interaction between sex and other sociocultural factors may predict greater sensitivity to postoperative pain, whereas the epidemiology and course of swallowing disorders has not been systematically investigated, along with the interaction between dysphagia, post-operative pain and emotional stress. Cardiac rehabilitation is a multifunctional intervention which may address all these functional domains, improving patients' prognosis.
The aim of the present study is to demonstrate the superiority of a multifunctional approach (OMT, systematic swallowing screening and specific treatment according to good clinical practice associated with psychological counseling) compared to local clinical practice in the management of pain and swallowing disorders.
Study Overview
Status
Intervention / Treatment
Detailed Description
The TITANIC trial will provide evidence on whether a multifunctional intervention systematically implemented in the cardiac rehabilitation setting will improve the clinical course and prognosis of patients with recent cardiac surgery.
The design is a randomized clinical trial with parallel group design. Patients aged over 18 undergoing elective cardiac surgery and admitted to IRCCS Fondazione Don Gnocchi, Santa Maria Nascente, Milan, for cardiac rehabilitation will be randomized to standard post-acute treatments (cardiovascular training, monitoring and logopedic treatment only in case of swallowing dysfunction) compared with an experimental approach which consists of osteopathic manipulative treatment (OMT) treatments, swallowing screen protocol, psychological assessment and counseling.
This study may help in the identification of a new diagnostic-therapeutic pathway in cardiac surgery patients that allows a reduction in the use of analgesics and anti-inflammatories and increases the early detection of swallowing disorders. Furthermore, by allowing an integrated assessment of emotional needs, it can have a positive effect in reducing the need for post-operative clinical visits and assessments in the medium to long term, improving the patients' quality of life.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Milan, Italy
- IRCCS Fondazione Don Gnocchi, ONLUS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria (all the following must be satisfied):
- patients with recent cardiac surgery (within one month)
- without swallowing disorders already identified before discharge
- with the presence of chest pain (NRS>2).
Exclusion Criteria:
- patients who are unable to sign informed consent.
- patients with already known psychological/psychiatric disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment
The cases (active treatment) will be treated with an approach that includes osteopathic treatment for pain control (by the Osteopath Bruno Bordoni), systematic swallowing screening (Speech Therapist, Leone Stilo), psychological counseling (Psychologist, Eleonora Volpato, Giulia Novembre ).
The duration of treatment will be that of hospitalization, on average about 3 weeks.
The osteopathic treatment will last 5 sessions, while the counseling will have one session at the admission and one at the discharge and up to two sessions a week (variable according to individual needs); the swallowing screening will have one session at the admission and one at discharge and about two-three sessions a week (variable according to individual needs).
|
multidisciplinary approach with (OMT, psychological counseling, and therapists dedicated to swallowing disorders)
|
No Intervention: Controls
Controls will follow good clinical practice (in this case systematic screening from a swallowing point of view will not be applied, nor will osteopathic treatment and systematic psychological counseling be considered).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain release through the Brief Pain Inventory
Time Frame: Through study completion, an average of 4 weeks
|
To verify the effectiveness of the multifunctional rehabilitation approach in reducing pain assessed by the Brief Pain Inventory: likert scale with maximum pain intensity equal to 7-10.
|
Through study completion, an average of 4 weeks
|
Anxiety and depression control through the Hospital Anxiety and Depression Scale
Time Frame: Through study completion, an average of 4 weeks
|
To verify the effectiveness of the multifunctional rehabilitation approach in reducing anxiety and depression assessed by the Hospital Anxiety and Depression Scale (HADS), with maximum anxiety and depression equal to 15-21 points.
|
Through study completion, an average of 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To assess functional swallowing disorders post-cardiac surgery (Mealtime Assessment Scale)
Time Frame: Through study completion, an average of 4 weeks
|
Epidemiological framework of the cardiac surgery population, in terms of presence/absence of swallowing disorders.
MAS: points 0-36, with higher scores defining the worst outcome.
|
Through study completion, an average of 4 weeks
|
Anti-inflammatory drugs use (numbers of pills used)
Time Frame: Through study completion, an average of 4 weeks
|
Monitoring the use of anti-inflammatory drugs
|
Through study completion, an average of 4 weeks
|
LOS
Time Frame: Through study completion, an average of 4 weeks
|
Length of stay
|
Through study completion, an average of 4 weeks
|
Number of participants with persistent inflammatory status
Time Frame: Through study completion, an average of 4 weeks
|
The persistent inflammatory status will be described in terms of fever and PCR> 5 in at least two successive measurements 8 days apart)
|
Through study completion, an average of 4 weeks
|
Adherence to treatment
Time Frame: Through study completion, an average of 4 weeks
|
Monitoring of adherence to treatment using the 4-item Morisky, Green, and Levine Adherence Scale.
With a sum of scores of 8, from 6 to <8 or <6, patients can be classified as having high, medium or low adherence to therapy, respectively.
|
Through study completion, an average of 4 weeks
|
Quality of life improvement through the EuroQol Visual Analogue Scale (EuroQoL-VAS) questionnaire
Time Frame: Through study completion, an average of 4 weeks
|
Consisting of two parts.
The first explores 5 areas of interest: mobility, personal hygiene, social activities, pain and anxiety/depression.
Each individual area has, in turn, three levels of severity (no problem, problem of some size, problem of extreme seriousness).
The second section consists of a 20 cm visual analog scale (VAS) on which the patient indicates the best (score=0) or worst (score=100) possible state of health.
|
Through study completion, an average of 4 weeks
|
Cognitive impairment
Time Frame: Through study completion, an average of 4 weeks
|
Monitoring of cognitive abilities through the administration of the Montreal Cognitive Assessment Test (MOCA) scale, with a score more than 17,54 in the normal range. A raw and then corrected score: - less than 15.5 suggests the presence of a cognitive impairment; - between 15.5 and 17.54 assumes a borderline performance; - a score above 17.54 would show functioning within the normal range. |
Through study completion, an average of 4 weeks
|
Quality of life improvement through the Short Form-12 (SF-12) questionnaire
Time Frame: Through study completion, an average of 4 weeks
|
Scores can be reported as Z-scores (difference from the population mean, measured in standard deviations).
The population mean is 50 points.
The population standard deviation is 10 points.
Thus, each 10-point increase above or below 50 is one standard deviation from the mean.
|
Through study completion, an average of 4 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 06_08/02/2023
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart; Surgery, Heart, Functional Disturbance as Result
-
JESSICA GARCIA SUAREZUnknownHeart; Surgery, Heart, Functional Disturbance as ResultSpain
-
University of Sao PauloSamsung ElectronicsCompletedHeart; Surgery, Heart, Functional Disturbance as ResultBrazil
-
Oslo University HospitalUniversity of OsloCompletedHeart; Surgery, Heart, Functional Disturbance as ResultNorway
-
Azienda Ospedaliera Universitaria Integrata VeronaRecruitingHeart; Surgery, Heart, Functional Disturbance as ResultItaly
-
Tadas CesnaitisUnknownHeart; Surgery, Heart, Functional Disturbance as ResultLithuania
-
Indonesia UniversityCompletedOblique Versus Transverse Orientation Approach for Internal Jugular Venous Cannulation in PediatricsPediatric ALL | Heart; Surgery, Heart, Functional Disturbance as ResultIndonesia
-
Indonesia UniversityCompletedHeart; Surgery, Heart, Functional Disturbance as ResultIndonesia
-
University Hospital, Basel, SwitzerlandCompletedSelf Efficacy | Heart; Surgery, Heart, Functional Disturbance as ResultSwitzerland
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterCompletedAnesthesia | Opioid Use | Heart; Surgery, Heart, Functional Disturbance as ResultUnited States
-
Indonesia UniversityCompletedHeart; Surgery, Heart, Functional Disturbance as ResultIndonesia
Clinical Trials on Multifunctional rehabilitation treatment
-
University of MichiganNational Institute of Neurological Disorders and Stroke (NINDS)CompletedParkinson DiseaseUnited States
-
EstimME Ltd.Completed
-
Near East University, TurkeyCompleted
-
Second Affiliated Hospital, School of Medicine,...UnknownSubluxation of Lens | Surgical Instruments,CataractChina
-
Chang Gung Memorial HospitalUnknown
-
Shanghai University of Traditional Chinese MedicineFudan UniversityRecruiting
-
Azienda Unita' Sanitaria Locale Di ModenaAzienda Unità Sanitaria Locale Reggio Emilia; University of Modena and Reggio... and other collaboratorsCompletedAmyotrophic Lateral SclerosisItaly
-
The Defense and Veterans Brain Injury CenterEvans Army Community HospitalActive, not recruitingTraumatic Brain Injury | Vestibular ProblemUnited States
-
The Greater Poland Cancer CentreNational Science Centre, PolandRecruitingBrain Tumors | RadiotherapyPoland
-
Reuth Rehabilitation HospitalCompleted